Precision Business Insights
Portfolio

 

Digital Therapeutics Market

: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

Global Digital Therapeutics Market: By Application (Obesity, Diabetes, Central Nervous System Diseases, Cardio Vascular Disorders, Respiratory Disease, Others), By End User (Healthcare Providers, Payers, Employees, Others), By Region

 

Global Digital Therapeutics Market Dynamics:

Global digital therapeutics market is primarily driven by increase in the usage of internet and adaptation of digital devices such as smartphones around the world. In addition, growing awareness and adaptation of telemedicine and digital healthcare services are expected to boost the market share in future. Moreover, through the digital therapeutics healthcare professionals can provide services to remote places. Technological advancements coupled with the growth in prevalence of chronic diseases such as neurological disorders, diabetes, and others are expected to bolster the market growth over the forecast period. However, lack of digital health services in remote places, patient data privacy, and resistance from the traditional healthcare providers are expected to hamper the global digital therapeutics market over the forecast period.

 

Global Digital Therapeutics Market Scope:

Global digital therapeutics market is segmented based on application, provider, and region

 

Based on application, market is segmented into

  • Obesity
  • Diabetes
  • Central Nervous System Disorders
  • CardioVascular Diseases
  • Respiratory Disease
  • Others

 

Based on end user, market is segmented into

  • Healthcare Providers
  • Payers
  • Employees
  • Others

 

Based on region, market is segmented into

  • North America
  • Latin America
  • Asia Pacific
  • The Middle East and Africa
  • Europe

 

Global Digital Therapeutics Market Summary:

Global digital therapeutics is still at development stage, few market players are present in the market. The advent of new companies and introduction of innovative digital therapies expected to boost the market over the forecast period. For instance, in November 2017, U.S. FDA has approved Proteus Digital Healths ABILIFY MYCYTE, aripirazole tablet with the sensor enables track the patient’s medications with the help of a wearable patch. Furthermore, market players are collaborating with other companies to provide digital therapy for the patients. For instance, in March 2017, Sanofi S.A. has collaborated agreement with Voluntis S.A. to deliver digital insulin titration solutions, featuring mobile phone application for type -II Diabetes.

 

Global Digital Therapeutics Market Regional Analysis:

Geographically digital therapeutics market is divided into five key regions, i.e. Europe, North America, Latin America, Asia Pacific, and The Middle East and Africa. North America digital therapeutics market is driven by the presence of key market players, well-established healthcare infrastructure, rise in the health expenditure and technological advancements in the region. Furthermore, favorable health policies in the region also expected to boost the market share. Asia Pacific expected to register the significant growth rate over the forecast period, owing to increase in adaptation of digital devices and growing awareness related to digital healthcare segment. In addition, rapid urbanization coupled with increase in healthcare spending expected to boost the market share especially in developing countries such as India and China. China digital therapeutics market projected to have notable growth rate owing to the technological advancements and increase in the aging population that require continuous monitoring and treatment of chronic conditions.

 

Competition Assessment: 

Some of the players in global Digital Therapeutics market include

  • Omada Health Inc. (U.S.)
  • Digital Health, Inc. (U.S.)
  • Livongo Health (U.S.)
  • WellDoc Inc. (U.S.)
  • io Inc. (U.S.)
  • Noom Inc. (U.S.)
  • 2Morrow Inc. (U.S.)
  • Propeller Health (U.S.)
  • Mango Health, Inc. (U.S.)
  • Canary Health Inc. (U.S.)
  • Bupa (U.K)

 

Notable Market Developments: 

  • In October 2016, Bupa UK collaborated with the SilverCloud Health to launch new online cognitive behavioral therapy (CBT) for wide range of mental conditions including depression and anxiety.

 

 Key Features of the Report:

  • The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

  1. Executive Summary
  2. Global Digital Therapeutics Market Introduction
    • Global Digital Therapeutics Market – Taxonomy
    • Global Digital Therapeutics Market –Definitions
      • Application
      • End User
  1. Global Digital Therapeutics Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Digital Therapeutics Market Dynamic Factors – Impact Analysis
    • Global Digital Therapeutics Market – Competition Landscape
    • Epidemiology
  2. Global Digital Therapeutics Market Analysis,2013 – 2017 and Forecast, 2018 – 2024
    • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global Digital Therapeutics Market, By Application, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Obesity
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Diabetes
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Central Nervous System Disorders
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • CardioVascular Diseases
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Respiratory Disease
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Digital Therapeutics Market Forecast, By End User,2013 – 2017 and Forecast, 2018 – 2024
    • Healthcare Providers
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Payers
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Employees
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Digital Therapeutics Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Digital Therapeutics Market – Opportunity Analysis Index, By Application, By End User and Region, 2018 – 2024
  2. North America Digital Therapeutics MarketAnalysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Obesity
      • Diabetes
      • Central Nervous System Disorders
      • CardioVascular Diseases
      • Respiratory Disease
      • Others
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Healthcare Providers
      • Payers
      • Employees
      • Others
    • Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US.
      • Canada
    • North America Digital Therapeutics Market – Opportunity Analysis Index, By Application, By End User and Country, 2018 – 2024
    • North America Digital Therapeutics Market Dynamics – Trends
  3. Europe Digital Therapeutics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Obesity
      • Diabetes
      • Central Nervous System Disorders
      • CardioVascular Diseases
      • Respiratory Disease
      • Others
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Healthcare Providers
      • Payers
      • Employees
      • Others
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Digital Therapeutics Market – Opportunity Analysis Index, By Application, By End User and Country, 2018 – 2024
    • Europe Digital Therapeutics Market Dynamics – Trends
  4. Asia-Pacific Digital Therapeutics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Obesity
      • Diabetes
      • Central Nervous System Disorders
      • CardioVascular Diseases
      • Respiratory Disease
      • Others
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Healthcare Providers
      • Payers
      • Employees
      • Others
    • Country Analysis2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Digital Therapeutics Market – Opportunity Analysis Index, By Application, By End User and Country, 2018 – 2024
    • Asia-Pacific Digital Therapeutics Market Dynamics – Trends
  5. Latin America Digital Therapeutics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Obesity
      • Diabetes
      • Central Nervous System Disorders
      • CardioVascular Diseases
      • Respiratory Disease
      • Others
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Healthcare Providers
      • Payers
      • Employees
      • Others
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Digital Therapeutics Market – Opportunity Analysis Index, By Application, By End User and Country, 2018 – 2024
    • Latin America Digital Therapeutics Market Dynamics – Trends
  6. Middle East and Africa Digital Therapeutics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Application Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Obesity
      • Diabetes
      • Central Nervous System Disorders
      • CardioVascular Diseases
      • Respiratory Disease
      • Others
    • End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Healthcare Providers
      • Payers
      • Employees
      • Others
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Digital Therapeutics Market – Opportunity Analysis Index, By Application, By End User and Country, 2018 – 2024
    • MEA Digital Therapeutics Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Product Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Omada Health Inc. (U.S.)
      • Digital Health, Inc. (U.S.)
      • Livongo Health (U.S.)
      • WellDoc Inc. (U.S.)
      • io Inc. (U.S.)
      • Noom Inc. (U.S.)
      • 2Morrow Inc. (U.S.)
      • Propeller Health (U.S.)
      • Mango Health, Inc. (U.S.)
      • Canary Health Inc. (U.S.)
      • Bupa (U.K)
  1. Research Methodology
  2. Key Assumptions and Acronyms

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

$ 3,000.00$ 8,900.00
Clear selection

Select License Type

Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner
FacebookTwitterLinkedinEmail

Our Clients

Testimonials